As of June 19, 2025, Oragenics Inc (OGEN) reports a Net Margin of -54862.52%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Oragenics Inc's Net Margin
Over recent years, Oragenics Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | -54862.52% |
| 2023-12-31 | -54862.52% |
| 2022-12-31 | -10992.31% |
| 2021-12-31 | -17455.56% |
This slight upward trend highlights how Oragenics Inc manages its overall profitability and cost control over time.
Comparing Oragenics Inc's Net Margin to Peers
To better understand Oragenics Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Oragenics Inc (OGEN) | -54862.52% |
| Liminal BioSciences Inc (LMNL) | 124.69% |
| Forward Pharma A/S (FWP) | 73.37% |
| Sunshine Biopharma Inc (SBFM) | -14.72% |
| ARCA Biopharma Inc (ABIO) | -26.25% |
| Ocuphire Pharma Inc (OCUP) | -52.42% |
Compared to its competitors, Oragenics Inc's Net Margin is lower than all peers, which may indicate challenges in controlling expenses or competitive pricing pressures.